Stock data

達爾膚 (6523)

達爾膚 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$70.05M, down 13.4% from a year earlier. EPS over the last four quarters totals NT$6.61.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 達爾膚 in Insightr